- Unitaid, CHAI, and Wits RHI enter into a landmark agreement with Dr. Reddy’s to make HIV prevention tool lenacapavir affordable in LMICs European AIDS Treatment Group
- Indian drugmakers Dr Reddy’s, Hetero to sell generic HIV prevention drug for $40 a year Reuters
- Lenacapavir: Landmark deal paves way for cheaper HIV/ Aids protection jab BBC
- Generics makers to sell Gilead’s Yeztugo at $40 a year under deals with Gates Foundation, others Fierce Pharma
- UNITAID / HIV PREVENTION TOOL UN Media
Unitaid, CHAI, and Wits RHI enter into a landmark agreement with Dr. Reddy’s to make HIV prevention tool lenacapavir affordable in LMICs European AIDS Treatment GroupIndian drugmakers Dr Reddy’s, Hetero to sell generic HIV prevention drug for $40 a year ReutersLenacapavir: Landmark deal paves way for cheaper HIV/ Aids protection jab BBCGenerics makers to sell Gilead’s Yeztugo at $40 a year under deals with Gates Foundation, others Fierce PharmaUNITAID / HIV PREVENTION TOOL UN Media by Soban News (international And National News)